Christopher Viehbacher
President and CEO at Biogen Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Biogen Inc., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Biogen Inc. June 9, 202699.4%
-
Biogen Inc. June 17, 202599.2%
-
Biogen Inc. June 20, 202499.3%
-
Biogen Inc. June 26, 202398.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Braveheart Bio Inc. | Open-market purchase | +83,333 | $18.00 | $1,499,994 |
| Feb 6, 2026 | Biogen Inc. | Option exercise | +9,008 | — | — |
| Feb 6, 2026 | Biogen Inc. | Shares withheld for tax | −4,356 | $201.18 | $876,340 |
| Feb 6, 2026 | Biogen Inc. | Option exercise | +15,453 | — | — |
| Feb 6, 2026 | Biogen Inc. | Shares withheld for tax | −6,624 | $201.18 | $1,332,616 |
| Dec 1, 2025 | Biogen Inc. | Option exercise | +7,040 | — | — |
| Dec 1, 2025 | Biogen Inc. | Shares withheld for tax | −3,404 | $177.78 | $605,163 |
| Feb 7, 2025 | Biogen Inc. | Option exercise | +9,008 | — | — |
| Feb 7, 2025 | Biogen Inc. | Shares withheld for tax | −3,201 | $141.35 | $452,461 |
Questions about Christopher Viehbacher
What boards is Christopher Viehbacher on?
Christopher Viehbacher sits on the boards of Biogen Inc. and Braveheart Bio Inc.
What company is Christopher Viehbacher the CEO of?
Christopher Viehbacher is President and CEO of Biogen Inc.
How long has Christopher Viehbacher served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.